A successful Switch from prednisone to budesonide for neuropsychiatric adverse effects in a patient with ileal Crohn's disease [15]

American Journal of Gastroenterology

Volumn 96, Issue 6, 2001, Pages 1953-1954

  Jones, Michael P ^a   Sloan, Sheldon S ^b   Rabine, John C ^b   Ebert, Christine C ^b   Huang, Cheng Fang ^b   Kahrilas, Peter J ^b  

^a Division of Hepatology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BUDESONIDE; CORTICOSTEROID; HYPNOTIC AGENT; MESALAZINE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; AFFECTIVE NEUROSIS; ANGER; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HUMAN; ILEUM DISEASE; INSOMNIA; IRRITABILITY; LETTER; MENTAL DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME; VOMITING;

EID: 0034972983     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02480-7     Document Type: Letter

References (3)

1. Corticosteroid-induced adverse psychiatric effects: Incidence, diagnosis and management
2. Corticosteroids and peptic ulcer: Meta-analysis of adverse events during steroid therapy
3. Budesonide versus prednisone in the treatment of active Crohn's disease